City News Blog

Browse Categories

Accountancy (12)
Automotive (28)
Banking (117)
Brewery (4)
Brokerage (3)
City of London (2)
Commodities (5)
Construction (21)
Courts (7)
Defence (4)
Economics (152)
Electronics (3)
Employment (12)
Energy (20)
Engineering (22)
EU (4)
Financial Services (75)
Food Production (21)
Football (4)
Fund Management (13)
Healthcare (4)
Insurance (48)
Internet (6)
Leisure (72)
Manufacturing (14)
Markets (9)
Media (83)
Mergers and Acquisitions (3)
Mobile (1)
Oil (78)
Pharmaceuticals (15)
Politics (7)
Property (56)
Remuneration (2)
Retail (128)
Sales (1)
Small Business (1)
Support Services (41)
Technology (41)
Telecommunications (79)
Transport (88)

Pharmaceuticals News

The best medicine for the NHS at 60
As spending growth slows, the health service in all four parts of the UK needs to demonstrate through reform and innovation that it can deliver improvements

Legal decision boosts AstraZeneca
Shares in AstraZeneca rose nearly 5 per cent on Wednesday after a US legal ruling pushed back the likely launch of a generic version of Seroquel, its blockbuster schizophrenia medicine, until 2011

UnitedHealth cuts its forecast again
US health insurer slashed its earnings forecast for a second time this year, blaming "an intensely competitive commercial business environment", as the company announced it had settled a class-action suit for more than $900m

AstraZeneca sees off generic rival
Shares in the drugmaker surged after it won a US court case against a generic challenge to Seroquel, a treatment for schizophrenia that is its second biggest selling drug

NHS celebrations clouded by threat to founding principles
As Britain's tax-funded National Health Service prepares to celebrate its 60th birthday on Saturday, an overwhelming majority of those who use the system fear its core...

Top-up payments 'would end equal access'
Almost nine out of 10 adults in the UK believe.a scheme under consideration by the government runs counter to the founding principles of the NHS

Southern Cross management feel investors' dismay
Investors in Southern Cross Healthcare have criticised the nursing home's senior management as the company's shares slid a further 27 per cent

Roche focus to include primary care
The new chief executive of Roche has embraced a broadening of the Swiss pharmaceutical group's focus from hospital-based medicines to primary care treatments

Appetite for health loses its edge
When the chief executive of Southern Cross Healthcare decided to borrow £46m to acquire 20 nursing homes, he thought it would be a straightforward transaction

GSK faces US delay on cancer vaccine
GlaxoSmithKline, the UK-based pharmaceutical company, is unlikely to receive US approval for its key cervical cancer vaccine until 2010 at the earliest

Southern Cross shares plunge
The nursing home group's shares fell by almost 75% after saying booking had slowed and it had negotiated a temporary waiver on its banking covenants

Shot in the arm for NHS patient rights
A strengthened legal right for patients to receive all drugs and treatments approved by the National Institute for Clinical Excellence will be promised today as part...

Biotech chief quits AstraZeneca arm
David Mott's departure as MedImmune head came as a surprise. His contract suggests he would remain to guide integration and help ensure senior officials do not leave

Consort hit by drug withdrawal
Pfizer's decision to pull its diabetes drug Exubera from the market has dragged on the profits of the medical device maker formerly known as Bespak

Patients to be told about clinical trials
The move aims to make Britain's NHS a more attractive place for pharmaceutical companies to do medical research and to improve patients' access to innovative treatments